ClinicalTrials.Veeva

Menu

Central Venous Catheter-related Complications in Patients Under Anticancer Treatment (KTcCHO)

C

Centre Hospitalier Alpes Leman

Status

Not yet enrolling

Conditions

Hematologic Malignancy
Solid Tumor
Central Venous Catheter Related Bloodstream Infection
Central Venous Catheter Thrombosis

Treatments

Device: central venous catheter

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Oncology and hemotology patients under anticancer treatments are exposed to increased risks of central venous catheter-related complications due to the underlying cancer and its treament.

This prospective observational monocentric french study aims at describing the incidence of such complications, their morbimortality, and analyzing some risk factors in order to contribute to propose some strategies to reduce these complications' rate and consequences

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

All patients older than 18 years, with solid cancer or hematological malignancy receiving anticancer treatment in the outpatient medical department of Alpes Leman Hospital and having a central venous catheter been placed between the 11th of July 2022, and the 1st of January 2023.

Trial contacts and locations

0

Loading...

Central trial contact

Florence OBERKAMPF

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems